This Week in Nature

In this week's Nature Biotechnology, a University of Washington research team reports on a genomic approach for preventing the genetic side effects that have long been barriers to gene therapies. While gene therapies have been successfully developed for a number of diseases, insertional mutagenesis and genotoxicity, which usually manifest as a malignancy, hamper their widespread use.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.